| Literature DB >> 31547036 |
Ririko Mimura1,2, Kiwako Mori2,3, Hidemasa Torii2,3, Norihiro Nagai2, Misa Suzuki2,4, Sakiko Minami2, Yoko Ozawa2, Toshihide Kurihara5,6, Kazuo Tsubota7.
Abstract
High myopia may develop to pathologic myopia, which brings severe visual impairment; however, the etiology is not fully understood. We, therefore, investigated the relationship between the presence of posterior staphyloma and posterior ocular disorders by assessing the patients with high myopia. A retrospective study was performed for the patients, who have more than 26 mm of the axial length and of whom fundus photography was taken with an ultra-widefield retinal imaging system. The objectives were 138 cases encompassing 229 eyes. In 138 cases, 91 were bilateral and 47 were unilateral. The averages ± SD of axial length of bilateral and unilateral were 28.8 ± 2.2 mm, 27.3 ± 1.2 mm, respectively, showing statistically significant difference. The number of eyes with and without posterior staphyloma were 107 (46.7%) and 122 (53.3%), respectively. Retinal detachment and retinal breaks are more observed in cases without posterior staphyloma (p = 0.017). Myopic choroidal neovascularization (mCNV) (p = 0.002), chorioretinal atrophy (p < 0.001), retinoschisis (p < 0.001), and optic neuropathy (p = 0.038) are more often seen in cases with posterior staphyloma. In conclusion, the prevalence rates of myopic choroidal neovascularization, retinal choroidal atrophy, and optic neuropathy were significantly higher with posterior staphyloma. The rate of periocular disorders such as retinal detachment was significantly higher without posterior staphyloma. These results indicate associations between types of pathological myopia and presence or absence of posterior staphyloma analyzed by ultra-widefield retinal imaging.Entities:
Keywords: axial length; high myopia; pathological myopia; staphyloma
Year: 2019 PMID: 31547036 PMCID: PMC6832756 DOI: 10.3390/jcm8101505
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flowchart of selecting the patients in this study.
Characteristics of high myopia patients.
| All | Men | Women | |||
|---|---|---|---|---|---|
| Subjects | 138 | 78 (56.4) | 60 (43.6) | ||
| Age (yrs) | 63.1 ± 13.5 | 62.1 ± 12.5 | 64.5 ± 14.7 | 0.306 | † |
| AXL (mm) | 28.1 ± 2.2 | 28.1 ± 2.3 | 28.2 ± 2.1 | 0.822 | † |
| Staphyloma | 107 (46.7) | 51 (47.7) | 56 (52.3) | 0.033 | †† |
Data represent means ± standard deviations, AXL: axial length, Staphyloma: posterior staphyloma, †: student t test, ††: chi-square test.
Comparison of bilateral and unilateral axial elongation.
| Bilateral | Unilateral | |||
|---|---|---|---|---|
| All | 91 (65.9) | 47 (34.1) | ||
| Men | 49 (53.8) | 29 (61.7) | 0.469 | † |
| Women | 42 (46.2) | 18 (38.3) | ||
| Age (yrs) | 63.0 ± 14.0 | 63.4 ± 12.4 | 0.881 | †† |
| AXL (mm) | 28.8 ± 2.2 | 27.3 ± 1.2 | <0.001 | †† |
Data represent means ± standard deviations, AXL: axial length, Bilateral: both eyes with AXL not less than 26 mm, Unilateral: one eye with AXL not less than 26 mm, †: chi-square test, ††: student t test.
Relationship of axial length to factors.
| AXL | ||||||
|---|---|---|---|---|---|---|
| 26.00 to 26.79 mm | 26.80 to 27.67 mm | 27.68 to 29.76 mm | 29.77 mm≤ | |||
| Subjects | All | 57 | 58 | 57 | 57 | |
| Men | 33 (57.9) | 34 (58.6) | 24 (42.1) | 36 (63.2) | 0.119 | |
| Women | 24 (42.1) | 24 (41.4) | 33 (57.9) | 21 (36.8) | ||
| Staphyloma | All | 27 (47.4) | 30 (51.7) | 23 (40.4) | 27 (47.4) | 0.675 |
| Men | 16 (48.5) | 12 (35.3) | 6 (25.0) | 17 (47.2) | 0.228 | |
| Women | 11 (45.8) | 18 (75.0) | 17 (51.5) | 10 (47.6) | 0.150 | |
| Curtin ( | Ⅰ | 14 | 17 | 14 | 23 | |
| Ⅱ | 9 | 8 | 7 | 3 | ||
| Ⅲ | 3 | 4 | 0 | 1 | ||
| Ⅳ | 0 | 0 | 0 | 0 | ||
| Ⅴ | 1 | 0 | 1 | 0 | ||
| Ⅵ | 0 | 1 | 1 | 0 | ||
| Ⅶ-Ⅹ | 0 | 0 | 0 | 0 | 0.391 | |
| Ohno–Matsui ( | Ⅰ | 14 | 18 | 15 | 23 | |
| Ⅱ | 9 | 8 | 7 | 3 | ||
| Ⅲ | 3 | 4 | 0 | 1 | ||
| Ⅳ | 0 | 0 | 0 | 0 | ||
| Ⅴ | 1 | 0 | 1 | 0 | 0.334 | |
| Disorders | RD | 17 (27.8) | 17 (29.3) | 16 (28.1) | 13 (22.8) | 0.784 |
| RVO | 0 (0.0) | 1 (1.7) | 0 (0.0) | 4 (7.0) | 0.032 | |
| ERM | 3 (5.3) | 5 (8.6) | 8 (14.0) | 14 (24.6) | 0.013 | |
| Schisis | 1 (1.8) | 3 (5.2) | 5 (8.8) | 8 (14.0) | 0.076 | |
| MH | 4 (7.0) | 4 (6.9) | 1 (1.8) | 5 (8.9) | 0.425 | |
| mCNV | 1 (1.8) | 6 (10.3) | 4 (7.0) | 1 (1.8) | 0.102 | |
| Atrophy | 7 (18.9) | 13 (35.1) | 10 (27.0) | 7 (18.9) | 0.388 | |
| Neuropathy | 22 (38.6) | 15 (25.9) | 11 (19.3) | 14 (24.6) | 0.122 |
AXL: axial length; Staphyloma: posterior staphyloma; Curtin: Curtin’s classification; Ohno–Matsui: Ohno–Matsui’s classification; RD: retinal detachment and retinal tear; RVO: central retinal vein occlusion and branch retinal vein occlusion; ERM: epiretinal membrane; Schisis: retinoschisis; MH: macular hole; mCNV: myopic choroidal neovascularization; Atrophy: chorioretinal atrophy; Neuropathy: glaucoma and myopic optic neuropathy.
Comparison in the presence of posterior staphyloma.
| Non Staphyloma | Staphyloma | |||
|---|---|---|---|---|
| Age (yrs) | 59.4 ± 13.1 | 67.8 ± 12.6 | <0.001 | † |
| AXL (mm) | 28.5 ± 2.1 | 28.4 ± 2.1 | 0.783 | † |
| Disorders | ||||
| RD ( | 42 | 21 | 0.017 | †† |
| RVO ( | 3 | 2 | 1.000 | †† |
| ERM ( | 12 | 18 | 0.169 | †† |
| Schisis ( | 1 | 16 | <0.001 | †† |
| MH ( | 4 | 10 | 0.094 | †† |
| mCNV (n) | 1 | 11 | 0.002 | †† |
| Atrophy ( | 5 | 32 | <0.001 | †† |
| Neuropathy ( | 26 | 36 | 0.038 | †† |
Data represent means ± SDs, †: student t test, ††: chi-square test; AXL: axial length; Staphyloma: posterior staphyloma; RD: retinal detachment and retinal tear; RVO: central retinal vein occlusion and branch retinal vein occlusion; ERM: epiretinal membrane; Schisis: retinoschisis; MH: macular hole; mCNV: myopic choroidal neovascularization; Atrophy: chorioretinal atrophy; Neuropathy: glaucoma and myopic optic neuropathy.
Figure 2The rate of presence of posterior staphyloma in each ocular disorder. RD has a lower presence rate of posterior staphyloma, whereas schisis, mCNV, atrophy, and neuropathy have a higher presence rate of posterior staphyloma. RD: retinal detachment and retinal tear; RVO: central retinal vein occlusion and branch retinal vein occlusion; ERM: epiretinal membrane; Schisis: retinoschisis; MH: macular hole; mCNV: myopic choroidal neovascularization; Atrophy: chorioretinal atrophy; Neuropathy: glaucoma and myopic optic neuropathy. (* p < 0.05, ** p < 0.01, *** p < 0.001).
Classification of posterior staphyloma and disorders. (A) Curtin’s classification. (B) Ohno–Matsui’s classification.
|
( | |||||||||
|
|
|
| |||||||
|
|
|
|
|
|
|
| |||
| total ( | 107 | 68 | 27 | 8 | 0 | 2 | 2 | 0 | |
| RD | 21 | 16 (23.5) | 4 (14.8) | 1 (12.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.683 |
| RVO | 2 | 1 (1.5) | 1 (3.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.941 |
| ERM | 18 | 16 (23.5) | 2 (7.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.176 |
| Schisis | 16 | 11 (16.2) | 5 (18.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.652 |
| MH | 10 | 7 (10.4) | 2 (7.4) | 1 (12.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.949 |
| mCNV | 11 | 7 (10.3) | 1 (3.7) | 2 (25.0) | 0 (0.0) | 0 (0.0) | 1 (50.0) | 0 (0.0) | 0.147 |
| Atrophy | 32 | 20 (29.4) | 10 (37.0) | 1 (12.5) | 0 (0.0) | 0 (0.0) | 1 (50.0) | 0 (0.0) | 0.548 |
| Neuropathy | 36 | 24 (35.3) | 8 (29.6) | 3 (37.5) | 0 (0.0) | 1 (50.0) | 0 (0.0) | 0 (0.0) | 0.812 |
| ( | |||||||||
|
|
|
| |||||||
|
|
|
|
|
| |||||
| total ( | 107 | 70 | 27 | 8 | 0 | 2 | |||
| RD | 21 | 16 (22.9) | 4 (14.8) | 1 (12.5) | 0 (0.0) | 0 (0.0) | 0.658 | ||
| RVO | 2 | 1 (1.4) | 1 (3.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.859 | ||
| ERM | 18 | 16 (22.9) | 2 (7.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.135 | ||
| Schisis | 16 | 11 (15.7) | 5 (18.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.560 | ||
| MH | 10 | 7 (10.1) | 2 (7.4) | 1 (12.5) | 0 (0.0) | 0 (0.0) | 0.926 | ||
| mCNV | 11 | 8 (11.4) | 1 (3.7) | 2 (25.0) | 0 (0.0) | 0 (0.0) | 0.324 | ||
| Atrophy | 32 | 21 (30.0) | 10 (37.0) | 1 (12.5) | 0 (0.0) | 0 (0.0) | 0.446 | ||
| Neuropathy | 36 | 24 (34.3) | 8 (29.6) | 3 (37.5) | 0 (0.0) | 1 (50.0) | 0.919 | ||
Staphyloma: posterior staphyloma; RD: retinal detachment and retinal tear; RVO: central retinal vein occlusion and branch retinal vein occlusion; ERM: epiretinal membrane; Schisis: retinoschisis; MH: macular hole; mCNV: myopic choroidal neovascularization; Atrophy: chorioretinal atrophy; Neuropathy: glaucoma and myopic optic neuropathy; Staphyloma: posterior staphyloma; RD: retinal detachment and retinal tear; RVO: central retinal vein occlusion and branch retinal vein occlusion; ERM: epiretinal membrane; Schisis: retinoschisis; MH: macular hole; mCNV: myopic choroidal neovascularization; Atrophy: chorioretinal atrophy; Neuropathy: glaucoma and myopic optic neuropathy.
Figure 3Classification of posterior staphyloma in each ocular disorder in two classifications, Curtin’s classification (A) and Ohno–Matsui’s classification (B). Among the classes of posterior staphyloma, no association is observed in each disorder in both classifications. Staphyloma: posterior staphyloma; RD: retinal detachment and retinal tear; RVO: central retinal vein occlusion and branch retinal vein occlusion; ERM: epiretinal membrane; Schisis: retinoschisis; MH: macular hole; mCNV: myopic choroidal neovascularization; Atrophy: chorioretinal atrophy; Neuropathy: glaucoma and myopic optic neuropathy.